Stem cell-based medicine, where are we headed: [Media coverage] SCSS Symposium … – Biotechin.Asia
Biotechin.Asia |
Stem cell-based medicine, where are we headed: [Media coverage] SCSS Symposium …
Biotechin.Asia Stem cells and its therapeutic derivatives are striving to be a first-in-class medicine. Living cells have now become the active pharmaceutical ingredients (APIs) and hold a regular share in the pharmaceutical and biotech innovation and delivery pipelines. |
